| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. | Interim Chief Financial Officer | Common Stock | 126K | $599K | $4.74 | Aug 12, 2024 | Direct |
| Aldeyra Therapeutics, Inc. | Interim Chief Financial Officer | Stock Option (right to buy) | 252K | Mar 9, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | Aug 12, 2024 | 1 | -$51.3K | 4 | Aug 14, 2024 | Interim Chief Financial Officer |
| ALDX | Aldeyra Therapeutics, Inc. | Mar 11, 2024 | 1 | -$45K | 4/A | Apr 17, 2024 | Interim Chief Financial Officer |
| ALDX | Aldeyra Therapeutics, Inc. | Mar 9, 2024 | 2 | -$45K | 4 | Mar 12, 2024 | Interim Chief Financial Officer |
| ALDX | Aldeyra Therapeutics, Inc. | Feb 28, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Interim Chief Financial Officer |
| ALDX | Aldeyra Therapeutics, Inc. | Jul 15, 2022 | 1 | $0 | 4 | Jul 19, 2022 | Interim Chief Financial Officer |
| ALDX | Aldeyra Therapeutics, Inc. | May 10, 2022 | 0 | $0 | 3 | May 13, 2022 | Interim Chief Financial Officer |